The record
J&J's SEC filings document the Imerys/Cyprus talc-indemnification dispute and the July 2024 global settlement agreement among J&J, Imerys, Cyprus, and the claimants' committees; the Delaware Bankruptcy Court approved the settlement in October 2024, insurers' appeals were denied below, and a Third Circuit appeal was fully briefed and pending as of the Q2 2026 10-Q. The debtors' own joint motion (Bankr. D. Del. No. 19-10289, Doc 6376, filed July 13, 2024) quantifies the settlement: 'guaranteed to yield settlement proceeds of at least $505 million' — a $225 million J&J initial payment, plus insurance-proceeds contributions (the first $200 million and 50% of the next $160 million, subject to an aggregate capped guarantee of $280 million), plus Home Proceeds — payable no later than December 31, 2025. The Imerys and Cyprus Chapter 11 plans contemplate a single Talc Personal Injury Trust; a joint confirmation hearing began in April 2025 and continued to February 2026, and the official solicitation site (IandCtalc.com, maintained by court-appointed Solicitation Agent Kroll) states the trust is anticipated to be funded 'with more than $1 billion.'
Claim scope
The existence, parties, dollar structure, and procedural status of the Imerys/Cyprus settlement and bankruptcy proceedings, per J&J's SEC disclosures and the debtors' July 13, 2024 joint motion (Doc 6376): at least $505 million in guaranteed settlement proceeds ($225M initial payment + insurance contributions capped at $280M + Home Proceeds), payable by December 31, 2025.
What this source does not establish
J&J's own SEC filings state no dollar amount — the $505M figure is from the DEBTORS' joint motion, and describes a guaranteed minimum of settlement proceeds, not a 'J&J trust contribution.' The '$862 million trust' figure traces to press coverage of the SUPERSEDED January 31, 2024 proposed plans — it appears in neither the July 2024 settlement motion nor the operative November 5, 2024 Second Joint Plan — and must not be published. The 'more than $1 billion' figure is the solicitation agent's statement of anticipated trust funding, not a confirmed amount. Note the tension between EX-99.1 (July 2026: all talc-supplier disputes settled) and the Q2 2026 10-Q filed four days earlier (insurers' Third Circuit appeal pending).
Limitations
Cite the settlement amount only as: debtors' joint motion, Case No. 19-10289 (LSS), Doc 6376 (Bankr. D. Del. July 13, 2024). Confirmation of the plans remained pending as of the latest verified status. Archived copies: source-documents/imerys_jj_settlement_motion_doc6376_2024-07-13.pdf and imerys_second_joint_plan_doc6732_2024-11-05.pdf.
Source
Sec Filing — Joint Motion of the Imerys Debtors and the Cyprus Debtor for an Order (I) Approving the Settlement Agreement ... and (II) Approving the Sale of Certain Rights, In re Imerys Talc America, Inc., No. 19-10289 (LSS) (Bankr. D. Del. July 13, 2024), Doc 6376; J&J 10-K FY2025 (SEC accession 0000200406-26-000016); J&J 10-Q Q2 2026 (0000200406-26-000153)